IV Haloperidol for the Treatment of Headache in the ED
IV Haloperidol for the Treatment of Headache in the ED
Single center, double-blind, randomized, placebo-controlled trial evaluating analog pain
 scores in patients who present to the emergency department (ED) with a complaint of headache.
 A total of 150 patients age 13-55 presenting to the emergency department with headache will
 be enrolled from October 2015 - October 2016. Patients will be randomized and pain scores and
 side effects will be recorded at 0, 30, 60, and 90 minutes. Follow-up will be performed by
 telephone at 24 hours.
Inclusion Criteria:

 -  Emergency Department patients that complain of headache or migraine

 -  Males and females age 13-55

 -  English is primary language

 Exclusion Criteria:

 -  Abnormal blood pressure (>200/100)

 -  Sudden rapid onsent (normal to worst pain in minutes)

 -  Fever

 -  Trauma

 -  Any history of masses, strokes, head injury or other causes of abnormal anatomy

 -  QT greater than 450 ms on EKG

 -  Allergy to Haldon

 -  Any altered mental status (GCS <15)

 -  Pregnancy

 -  Any abnormalities on neurologic exam

 -  Any clinician concern that would require CT scan of brain

 -  Any prisoner or ward of state